Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COX6B1 gene.
Features include always present findings: Hyperketonemia, Generalized hypotonia, Cerebral visual impairment, and Hyperammonemia and others. 26 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 | Cerebral visual impairment, Enlarged brain ventricles (ventriculomegaly), Mental deterioration |
COX6B1 encodes cytochrome c oxidase subunit 6B1 (86 aa). Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. Highest expression in Heart Left Ventricle (378.6 TPM) and Heart Atrial Appendage (371.4 TPM).
Mitochondrial complex IV deficiency, nuclear type 7 is associated with mutations in the COX6B1 gene on chromosome 19.
COX6B1 is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for COX6B1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 21 always present features.
No clinical trials have been registered for mitochondrial complex IV deficiency, nuclear type 7.
6 publications have been identified in PubMed for mitochondrial complex IV deficiency, nuclear type 7. Research spans Review / Meta-Analysis (33%), Basic Science / Preclinical (33%), and Other (17%).
Zhang L (2025). [PMID: 39716856](https://pubmed.ncbi.nlm.nih.gov/39716856/). *Adv Sci (Weinh)*. [Basic Science / Preclinical]
Kaiyrzhanov R (2025). [PMID: 39963288](https://pubmed.ncbi.nlm.nih.gov/39963288/). *Brain Commun*. [Other]
Iacobas DA (2025). [PMID: 41296444](https://pubmed.ncbi.nlm.nih.gov/41296444/). *Curr Issues Mol Biol*. [Basic Science / Preclinical]
Pham L (2024). [PMID: 39566165](https://pubmed.ncbi.nlm.nih.gov/39566165/). *Redox Biol*. [Review / Meta-Analysis]
Zhang X (2024). [PMID: 39850733](https://pubmed.ncbi.nlm.nih.gov/39850733/). *Front Neurol*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 9:39 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Muscles
4 |
Generalized hypotonia, Muscle weakness, Cytochrome C oxidase-negative muscle fibers |
Heart and blood vessels | 4 | Enlarged heart (cardiomegaly), High blood pressure in lung arteries (pulmonary arterial hypertension), Thickened heart muscle (hypertrophic cardiomyopathy) |
Eyes | 1 | Cerebral visual impairment |
Metabolism | 1 | Metabolic acidosis |
Digestive system | 1 | Feeding difficulties |
Lab test results | 1 | Increased circulating lactate concentration |
Arms and legs | 1 | Limb ataxia |
Lungs and breathing | 1 | High blood pressure in lung arteries (pulmonary arterial hypertension) |
Growth and development | 1 | Intrauterine growth retardation |
Age of onset: adolescence.